MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Maturities of short-terminvestments$56,822K Proceeds from exercisesof stock options$598K Net cash provided by(used in) investing...$42,400K Net cash provided by(used in) financing...$598K Canceled cashflow$14,422K Net decrease incash, cash...-$4,854K Canceled cashflow$42,998K Stock-based compensationexpense$4,647K Accrued expenses andother current...$1,229K Non-cash lease expense$151K Depreciation andamortization expense$49K Purchases of short-terminvestments$14,422K Net cash used inoperating activities-$47,852K Canceled cashflow$6,076K Net loss-$40,591K Prepaid expenses andother assets$11,046K Accounts payable-$1,016K Net amortization ofpremiums and accretion of...$754K Accounts receivable$366K Operating leaseliabilities-$155K
Cash Flow

Upstream Bio, Inc. (UPB)

Upstream Bio, Inc. (UPB)

source: myfinsight.com